摘要
在过去的几十年里,植物衍生产品(植物化学物质)被认为具有巨大的治疗潜力。在这些植物化学物质中,已经报道了不同的黄酮类化合物具有强大的抗癌活性。为了展示它们的抗癌潜力,这些类黄酮调节不同的信号通路。在这些途径中,据报道,哺乳动物雷帕霉素靶蛋白 (mTOR) 和相关的磷脂酰肌醇 3-激酶 (PI3K)/蛋白激酶 B (Akt) 信号级联反应是细胞存活、增殖和死亡/凋亡的关键调节剂。因此,针对这种级联反应可能是减轻细胞凋亡和抑制不同形式癌症增殖的理想策略。黄酮类化合物对 PI3K/Akt/mTOR 的靶向作用已在科学文献中得到充分证明。在目前的研究中,我们研究了各种黄酮类化合物的抗癌潜力,尤其是黄酮类、黄酮醇类和异黄酮类,包括芹菜素、木犀草素、黄芩素、橘皮素、表没食子儿茶素-3-没食子酸酯、染料木黄酮和黄豆苷元,尤其是处理 mTOR 靶向性。
关键词: 芹菜素、黄芩素、癌症预防、黄豆苷元、表没食子儿茶素-3-没食子酸酯、类黄酮、染料木黄酮、木犀草素、橘子素、mTOR。
Current Medicinal Chemistry
Title:mTOR Targeted Cancer Chemoprevention by Flavonoids
Volume: 28 Issue: 39
关键词: 芹菜素、黄芩素、癌症预防、黄豆苷元、表没食子儿茶素-3-没食子酸酯、类黄酮、染料木黄酮、木犀草素、橘子素、mTOR。
摘要: Over the past several decades, plant-derived products (phytochemicals) have been suggested to possess immense therapeutic potential. Among these phytochemicals, different flavonoids have been reported for their potent anticancer activity. To exhibit their anticancer potential, these flavonoids modulate different signaling pathways. Among these pathways, the mammalian target of rapamycin (mTOR) and associated phosphatidyl-inositol 3-kinase (PI3K)/protein kinase B (Akt) signaling cascade have been reported as a pivotal modulator of cell survival, proliferation, and death/apoptosis. Hence, targeting this cascade could be an ideal strategy to alleviate apoptosis and inhibit proliferation in different forms of cancer. The targeting of PI3K/Akt/mTOR by flavonoids have been well documented in the scientific literature. In the current study, we have studied the anticancer potential of various flavonoids, especially flavones, flavonols, and isoflavones that include apigenin, luteolin, baicalein, tangeretin, epigallocatechin- 3-gallate, genistein, and daidzein especially dealing with mTOR targeting.
Export Options
About this article
Cite this article as:
mTOR Targeted Cancer Chemoprevention by Flavonoids, Current Medicinal Chemistry 2021; 28 (39) . https://dx.doi.org/10.2174/0929867327666201109122025
DOI https://dx.doi.org/10.2174/0929867327666201109122025 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Epidemiological, Mechanistic and Potential Clinical Role of Androgen Receptor (AR) in Urothelial Carcinoma
Current Drug Targets Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: A Review of Recent Clinical Trials
Reviews on Recent Clinical Trials Review of the Contribution of Radiolabelled Tracers for Tumour Cell Status Imaging
Current Medical Imaging Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric and Teen Patients Allows Identifying Two Main Classes of Biological Processes Involved and New Potential Therapeutic Targets
Current Genomics Targeting the Epidermal Growth Factor Receptor: Exploring the Potential of Novel Inhibitor N-(3-Ethynylphenyl)-6, 7-bis (2-methoxyethoxy) Quinolin- 4-Amine Using Docking and Molecular Dynamics Simulation
Protein & Peptide Letters Prostaglandin E Synthase: A Novel Drug Target for Inflammation and Cancer
Current Pharmaceutical Design Inorganic Nanoparticles for Enhanced Photodynamic Cancer Therapy
Current Drug Discovery Technologies Vitamin D and Cancer Mortality: Systematic Review of Prospective Epidemiological Studies
Anti-Cancer Agents in Medicinal Chemistry The Possible Adverse Effects of Intramuscular Botulinum Toxin Injections and their Management
Current Drug Safety Therapeutic Potential of Natural Compounds in Lung Cancer
Current Medicinal Chemistry Synthesis and Cytotoxic Activities of a Curcumin Analogue and Its bis- Mannich Derivatives
Letters in Drug Design & Discovery Inflammation and Antiangiogenesis in Cancer
Current Medicinal Chemistry Epigenetic Changes Induced by Green Tea Catechins a re Associated with Prostate Cancer
Current Molecular Medicine KRAS Mutations in Lung Adenocarcinoma: Molecular and Epidemiological Characteristics, Methods for Detection, and Therapeutic Strategy Perspectives
Current Molecular Medicine Advances in Cancer Stem Cell Therapy: Targets and Treatments
Recent Patents on Regenerative Medicine Differentiation-Inducing Therapy for Solid Tumors
Current Pharmaceutical Design Identifying the Characteristics of the Hypusination Sites Using SMOTE and SVM Algorithm with Feature Selection
Current Proteomics ADAMTS9-AS2: A Functional Long Non-coding RNA in Tumorigenesis
Current Pharmaceutical Design Anti-Cancer Therapy: Targeting the Mevalonate Pathway
Current Cancer Drug Targets The Potential Role of Radiation Therapy in Bowens Disease: A Review of the Current Literature
Reviews on Recent Clinical Trials